Literature DB >> 15546343

Loss of heterozygosity in the HLA class I region in human pancreatic cancer.

E Ryschich1, O Cebotari, O V Fabian, F Autschbach, J Kleeff, H Friess, A Bierhaus, M W Büchler, J Schmidt.   

Abstract

An altered human leukocyte antigen (HLA) class I expression constitutes an important tumor-escape mechanism counteracting T-cell mediated immune responses. We utilized the technique of microsatellite analysis to characterize the loss of heterozygosity (LOH) in the HLA class I region in 24 samples of patients with human ductal pancreatic carcinoma. The expression of HLA class I and the infiltration by T cells were studied in parallel by standard immunohistochemistry. The present study demonstrates LOH in the HLA class I region in five patients with pancreatic carcinoma. Immunohistochemical analysis showed that pancreatic carcinomas were frequently characterized by a total or partial loss of expression in HLA class I antigen. The positive or negative LOH status corresponded with the expression analysis in eight cases. Reduction of HLA class I expression without LOH was found in 14 cases. Lymphocyte infiltration with CD3+, CD4+, and CD8+ T cells did not show significant differences between LOH-positive and LOH-negative tumors. In conclusion, LOH does not seem to be the only factor for the reduced expression of HLA class I antigen as well as for the T-cell infiltration in this type of tumor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546343     DOI: 10.1111/j.1399-0039.2004.00324.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

Review 1.  The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer.

Authors:  André Steven; Barbara Seliger
Journal:  Breast Care (Basel)       Date:  2018-02-02       Impact factor: 2.860

2.  Naïve rat umbilical cord matrix stem cells significantly attenuate mammary tumor growth through modulation of endogenous immune responses.

Authors:  Atsushi Kawabata; Naomi Ohta; Garret Seiler; Marla M Pyle; Susumu Ishiguro; Yong Qing Zhang; Kevin G Becker; Deryl Troyer; Masaaki Tamura
Journal:  Cytotherapy       Date:  2013-03-07       Impact factor: 5.414

3.  HLA-B influences integrin beta-1 expression and pancreatic cancer cell migration.

Authors:  Bailee H Sliker; Benjamin T Goetz; Raina Barnes; Hannah King; H Carlo Maurer; Kenneth P Olive; Joyce C Solheim
Journal:  Exp Cell Res       Date:  2020-03-16       Impact factor: 3.905

4.  Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma.

Authors:  Hans-Udo Kasper; Uta Drebber; Dirk-Ludger Stippel; Hans-Peter Dienes; Anton Gillessen
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

5.  Evolutionary Pressure against MHC Class II Binding Cancer Mutations.

Authors:  Rachel Marty Pyke; Wesley Kurt Thompson; Rany M Salem; Joan Font-Burgada; Maurizio Zanetti; Hannah Carter
Journal:  Cell       Date:  2018-09-20       Impact factor: 41.582

Review 6.  Ly49 receptors: innate and adaptive immune paradigms.

Authors:  Mir Munir A Rahim; Megan M Tu; Ahmad Bakur Mahmoud; Andrew Wight; Elias Abou-Samra; Patricia D A Lima; Andrew P Makrigiannis
Journal:  Front Immunol       Date:  2014-04-02       Impact factor: 7.561

Review 7.  Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond.

Authors:  Simona Pagliuca; Carmelo Gurnari; Marie Thérèse Rubio; Valeria Visconte; Tobias L Lenz
Journal:  Front Immunol       Date:  2022-09-05       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.